168 related articles for article (PubMed ID: 17117180)
1. HapMap-based study of the 17q21 ERBB2 amplicon in susceptibility to breast cancer.
Benusiglio PR; Pharoah PD; Smith PL; Lesueur F; Conroy D; Luben RN; Dew G; Jordan C; Dunning A; Easton DF; Ponder BA
Br J Cancer; 2006 Dec; 95(12):1689-95. PubMed ID: 17117180
[TBL] [Abstract][Full Text] [Related]
2. Association analysis of ERBB2 amplicon genetic polymorphisms and STARD3 expression with risk of gastric cancer in the Chinese population.
Qiu Y; Zhang ZY; Du WD; Ye L; Xu S; Zuo XB; Zhou FS; Chen G; Ma XL; Schneider ME; Xia HZ; Zhou Y; Wu JF; Yuan-Hong X; Zhang XJ
Gene; 2014 Feb; 535(2):225-32. PubMed ID: 24291029
[TBL] [Abstract][Full Text] [Related]
3. Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.
Benusiglio PR; Lesueur F; Luccarini C; McIntosh J; Luben RN; Smith P; Dunning A; Easton DF; Ponder BA; Pharoah PD
BMC Cancer; 2005 Jul; 5():81. PubMed ID: 16029503
[TBL] [Abstract][Full Text] [Related]
4. MGC9753 gene, located within PPP1R1B-STARD3-ERBB2-GRB7 amplicon on human chromosome 17q12, encodes the seven-transmembrane receptor with extracellular six-cystein domain.
Katoh M; Katoh M
Int J Oncol; 2003 Jun; 22(6):1369-74. PubMed ID: 12739007
[TBL] [Abstract][Full Text] [Related]
5. A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.
Marotta M; Chen X; Inoshita A; Stephens R; Budd GT; Crowe JP; Lyons J; Kondratova A; Tubbs R; Tanaka H
Breast Cancer Res; 2012 Nov; 14(6):R150. PubMed ID: 23181561
[TBL] [Abstract][Full Text] [Related]
6. Common ERBB2 polymorphisms and risk of breast cancer in a white British population: a case-control study.
Benusiglio PR; Lesueur F; Luccarini C; Conroy DM; Shah M; Easton DF; Day NE; Dunning AM; Pharoah PD; Ponder BA
Breast Cancer Res; 2005; 7(2):R204-9. PubMed ID: 15743501
[TBL] [Abstract][Full Text] [Related]
7. Heritable variation of ERBB2 and breast cancer risk.
Breyer JP; Sanders ME; Airey DC; Cai Q; Yaspan BL; Schuyler PA; Dai Q; Boulos F; Olivares MG; Bradley KM; Gao YT; Page DL; Dupont WD; Zheng W; Smith JR
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1252-8. PubMed ID: 19336545
[TBL] [Abstract][Full Text] [Related]
8. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Vallon-Christersson J; Grabau D; Arason A; Gunnarsson H; Agnarsson BA; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R25. PubMed ID: 20459607
[TBL] [Abstract][Full Text] [Related]
9. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
[TBL] [Abstract][Full Text] [Related]
10. Molecular dissection of 17q12 amplicon in upper gastrointestinal adenocarcinomas.
Maqani N; Belkhiri A; Moskaluk C; Knuutila S; Dar AA; El-Rifai W
Mol Cancer Res; 2006 Jul; 4(7):449-55. PubMed ID: 16849520
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of mouse Erbb2 gene in silico.
Katoh M; Katoh M
Int J Oncol; 2003 Sep; 23(3):831-5. PubMed ID: 12888924
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.
Lee SA; Haiman CA; Burtt NP; Pooler LC; Cheng I; Kolonel LN; Pike MC; Altshuler D; Hirschhorn JN; Henderson BE; Stram DO
BMC Med Genet; 2007 Dec; 8():72. PubMed ID: 18053149
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants at 5p12 and risk of breast cancer in Han Chinese.
Liu X; Qin Z; Shen H; Xue J; Jiang Y; Hu Z; Shen H; Wang S
J Hum Genet; 2012 Oct; 57(10):638-41. PubMed ID: 22832384
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study.
Einarsdóttir K; Rosenberg LU; Humphreys K; Bonnard C; Palmgren J; Li Y; Li Y; Chia KS; Liu ET; Hall P; Liu J; Wedrén S
Breast Cancer Res; 2006; 8(6):R67. PubMed ID: 17132159
[TBL] [Abstract][Full Text] [Related]
15. [DNA structural features on the borders of ERBB2 amplicons in breast cancer].
Matsenko NIu; Kovalenko SP
Mol Biol (Mosk); 2013; 47(5):818-27. PubMed ID: 25509354
[TBL] [Abstract][Full Text] [Related]
16. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer.
Dressman MA; Baras A; Malinowski R; Alvis LB; Kwon I; Walz TM; Polymeropoulos MH
Cancer Res; 2003 May; 63(9):2194-9. PubMed ID: 12727839
[TBL] [Abstract][Full Text] [Related]
18. Gene copy mapping of the ERBB2/TOP2A region in breast cancer.
Jacobson KK; Morrison LE; Henderson BT; Blondin BA; Wilber KA; Legator MS; O'Hare A; Van Stedum SC; Proffitt JH; Seelig SA; Coon JS
Genes Chromosomes Cancer; 2004 May; 40(1):19-31. PubMed ID: 15034864
[TBL] [Abstract][Full Text] [Related]
19. 655Val and 1170Pro ERBB2 SNPs in familial breast cancer risk and BRCA1 alterations.
Tommasi S; Fedele V; Lacalamita R; Bruno M; Schittulli F; Ginzinger D; Scott G; Eppenberger-Castori S; Calistri D; Casadei S; Seymour I; Longo S; Giannelli G; Pilato B; Simone G; Benz CC; Paradiso A
Cell Oncol; 2007; 29(3):241-8. PubMed ID: 17452776
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the chromosome 17q23 amplicon and breast cancer risk.
Kelemen LE; Wang X; Fredericksen ZS; Pankratz VS; Pharoah PD; Ahmed S; Dunning AM; Easton DF; Vierkant RA; Cerhan JR; Goode EL; Olson JE; Couch FJ
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1864-8. PubMed ID: 19454617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
